214 related articles for article (PubMed ID: 30215565)
1. Developing an optimal follow-up strategy based on the natural history of nonfunctioning pituitary adenomas.
Kim JH; Dho YS; Kim YH; Lee JH; Lee JH; Hong AR; Shin CS
J Neurosurg; 2018 Sep; 131(2):500-506. PubMed ID: 30215565
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
3. Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis.
Fernández-Balsells MM; Murad MH; Barwise A; Gallegos-Orozco JF; Paul A; Lane MA; Lampropulos JF; Natividad I; Perestelo-Pérez L; Ponce de León-Lovatón PG; Erwin PJ; Carey J; Montori VM
J Clin Endocrinol Metab; 2011 Apr; 96(4):905-12. PubMed ID: 21474687
[TBL] [Abstract][Full Text] [Related]
4. Gamma Knife surgery for patients with nonfunctioning pituitary macroadenomas: predictors of tumor control, neurological deficits, and hypopituitarism.
Starke RM; Williams BJ; Jane JA; Sheehan JP
J Neurosurg; 2012 Jul; 117(1):129-35. PubMed ID: 22577749
[TBL] [Abstract][Full Text] [Related]
5. Longitudinal evaluation of the natural history of conservatively managed nonfunctioning pituitary adenomas.
Lenders N; Ikeuchi S; Russell AW; Ho KK; Prins JB; Inder WJ
Clin Endocrinol (Oxf); 2016 Feb; 84(2):222-228. PubMed ID: 26291181
[TBL] [Abstract][Full Text] [Related]
6. The outcomes of conservatively observed asymptomatic nonfunctioning pituitary adenomas with optic nerve compression.
Hwang K; Kim YH; Kim JH; Lee JH; Yang HK; Hwang JM; Kim CY; Han JH
J Neurosurg; 2020 Jun; 134(6):1808-1815. PubMed ID: 32502994
[TBL] [Abstract][Full Text] [Related]
7. Tumor shrinkage after transsphenoidal surgery for nonfunctioning pituitary adenoma.
Berkmann S; Schlaffer S; Buchfelder M
J Neurosurg; 2013 Dec; 119(6):1447-52. PubMed ID: 24074495
[TBL] [Abstract][Full Text] [Related]
8. Comparison of MRI techniques for detecting microadenomas in Cushing's disease.
Grober Y; Grober H; Wintermark M; Jane JA; Oldfield EH
J Neurosurg; 2018 Apr; 128(4):1051-1057. PubMed ID: 28452619
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and treatment of pituitary adenomas.
Chanson P; Salenave S
Minerva Endocrinol; 2004 Dec; 29(4):241-75. PubMed ID: 15765032
[TBL] [Abstract][Full Text] [Related]
10. What is the natural history of nonoperated nonfunctioning pituitary adenomas?
Karavitaki N; Collison K; Halliday J; Byrne JV; Price P; Cudlip S; Wass JA
Clin Endocrinol (Oxf); 2007 Dec; 67(6):938-43. PubMed ID: 17692109
[TBL] [Abstract][Full Text] [Related]
11. Pituitary surgery and volumetric assessment of extent of resection: a paradigm shift in the use of intraoperative magnetic resonance imaging.
Serra C; Burkhardt JK; Esposito G; Bozinov O; Pangalu A; Valavanis A; Holzmann D; Schmid C; Regli L
Neurosurg Focus; 2016 Mar; 40(3):E17. PubMed ID: 26926057
[TBL] [Abstract][Full Text] [Related]
12. Nonfunctioning Pituitary Microadenomas: Should Imaging Interval be Extended? A Large Single-center Cohort Study.
Han AJ; Varlamov EV; Fleseriu M
J Clin Endocrinol Metab; 2022 Feb; 107(3):e1231-e1241. PubMed ID: 34648635
[TBL] [Abstract][Full Text] [Related]
13. Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study.
Feldkamp J; Santen R; Harms E; Aulich A; Mödder U; Scherbaum WA
Clin Endocrinol (Oxf); 1999 Jul; 51(1):109-13. PubMed ID: 10469480
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of Microsurgical Sublabial Approach (MSA) Versus Endoscopic Endonasal Approach (EEA) for the Treatment of Pituitary Adenomas Based on Radiological and Hormonal Outcome.
Mattogno PP; Mangiola A; Lofrese G; Vigo V; Anile C
Acta Neurochir Suppl; 2017; 124():101-106. PubMed ID: 28120060
[TBL] [Abstract][Full Text] [Related]
15. Clinically Nonfunctioning Pituitary Incidentalomas: Characteristics and Natural History.
Tresoldi AS; Carosi G; Betella N; Del Sindaco G; Indirli R; Ferrante E; Sala E; Giavoli C; Morenghi E; Locatelli M; Milani D; Mazziotti G; Spada A; Arosio M; Mantovani G; Lania AGA
Neuroendocrinology; 2020; 110(7-8):595-603. PubMed ID: 31525736
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma.
Berkmann S; Schlaffer S; Nimsky C; Fahlbusch R; Buchfelder M
J Neurosurg; 2014 Nov; 121(5):1166-75. PubMed ID: 25127413
[TBL] [Abstract][Full Text] [Related]
17. Potential utility of FLAIR in MRI-negative Cushing's disease.
Chatain GP; Patronas N; Smirniotopoulos JG; Piazza M; Benzo S; Ray-Chaudhury A; Sharma S; Lodish M; Nieman L; Stratakis CA; Chittiboina P
J Neurosurg; 2018 Sep; 129(3):620-628. PubMed ID: 29027863
[TBL] [Abstract][Full Text] [Related]
18. TSH-STAINING PITUITARY ADENOMAS: RARE, SILENT, AND PLURIHOROMONAL.
Polanco Santos C; Sandouk Z; Yogi-Morren D; Prayson R; Recinos P; Kennedy L; Hamrahian AH; Pantalone KM
Endocr Pract; 2018 Jun; 24(6):580-588. PubMed ID: 29949434
[TBL] [Abstract][Full Text] [Related]
19. Early morning cortisol levels as predictors of short-term and long-term adrenal function after endonasal transsphenoidal surgery for pituitary adenomas and Rathke's cleft cysts.
McLaughlin N; Cohan P; Barnett P; Eisenberg A; Chaloner C; Kelly DF
World Neurosurg; 2013 Nov; 80(5):569-75. PubMed ID: 22902358
[TBL] [Abstract][Full Text] [Related]
20. Preoperative octreotide treatment of growth hormone-secreting and clinically nonfunctioning pituitary macroadenomas: effect on tumor volume and lack of correlation with immunohistochemistry and somatostatin receptor scintigraphy.
Plöckinger U; Reichel M; Fett U; Saeger W; Quabbe HJ
J Clin Endocrinol Metab; 1994 Nov; 79(5):1416-23. PubMed ID: 7962337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
